Medical device companies are dealing with the impact of increasing regulations in a number of ways, including the ...

The result is a welcome endorsement of patritumab derxutecan's potential after the HER3-directed antibody-drug conjugate (ADC ...

Noom is best known for its eponymous app that helps people become healthier and lose weight by making changes to their diet ...

The complaint, filed by Express Scripts owner Cigna against the FTC and Commissioner Lina Khan, is seeking the retraction of ...

Novartis' CDK4/6 inhibitor Kisqali has claimed a broad FDA approval in early breast cancer that could give it an edge over ...

Philip Morris International (PMI) is selling inhaled drug specialist Vectura to Molex Asia Holdings for a fraction of the ...

In the ad for oral CGRP inhibitor Ubrelvy (ubrogepant), Williams is depicted as suffering from a migraine while in a talk ...

As a result, commercial teams are evolving as valuable partners to HCPs. From educating key experts before launch and ...

The critical need to improve prior authorisation processes might have reached its tipping point on the 17th January. That’s ...

Ioannis Sapountzis, head of global therapeutic areas at Boehringer, said that FIBRONEER-IPF is the largest trial in IPF ...

For the past eight years, the CDD for Biologics Summit has united computational and structural biologists, along with protein ...

Unearthing novel targets for radiopharmaceuticals from ACP3m, AVB6, AVB8, and PDL-1 with Philochem, TRIMT, Fusion-AstraZeneca ...